PLUS THERAPEUTICS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Plus Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Plus Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 271 %.
  • Plus Therapeutics, Inc. annual Return On Equity for 2023 was -806 %, a 319% decline from 2022.
  • Plus Therapeutics, Inc. annual Return On Equity for 2022 was -192 %, a 68.8% decline from 2021.
  • Plus Therapeutics, Inc. annual Return On Equity for 2021 was -114 %, a 68.8% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 271 +693 Jul 1, 2024 Sep 30, 2024
Q2 2024 473 +769 Apr 1, 2024 Jun 30, 2024
Q1 2024 5.23K +5.5K Jan 1, 2024 Mar 31, 2024
Q4 2023 -806 -613 -319% Oct 1, 2023 Dec 31, 2023
Q3 2023 -421 -260 -161% Jul 1, 2023 Sep 30, 2023
Q2 2023 -296 -158 -114% Apr 1, 2023 Jun 30, 2023
Q1 2023 -278 -164 -145% Jan 1, 2023 Mar 31, 2023
Q4 2022 -192 -78.4 -68.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -161 -30.5 -23.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -138 +21.4 +13.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -113 +100 +47% Jan 1, 2022 Mar 31, 2022
Q4 2021 -114 +251 +68.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -131 +79.7 +37.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -160 -31 -24% Apr 1, 2021 Jun 30, 2021
Q1 2021 -214 -939 -130% Jan 1, 2021 Mar 31, 2021
Q4 2020 -365 -4.33K -109% Oct 1, 2020 Dec 31, 2020
Q3 2020 -210 +1.68K +88.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -129 +625 +82.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 725 +952 Jan 1, 2020 Mar 31, 2020
Q4 2019 3.96K +4.17K Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.89K -1.71K -941% Jul 1, 2019 Sep 30, 2019
Q2 2019 -754 -553 -274% Apr 1, 2019 Jun 30, 2019
Q1 2019 -228 -34.9 -18.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -205 +24.8 +10.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -181 +68 +27.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -202 +19.4 +8.78% Apr 1, 2018 Jun 30, 2018
Q1 2018 -193 -1.78 -0.93% Jan 1, 2018 Mar 31, 2018
Q4 2017 -230 -57.7 -33.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -249 -97.4 -64.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -221 -102 -85.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -191 -160 -512% Jan 1, 2017 Mar 31, 2017
Q4 2016 -173 -2.18K -109% Oct 1, 2016 Dec 31, 2016
Q3 2016 -152 -554 -138% Jul 1, 2016 Sep 30, 2016
Q2 2016 -119 -555 -127% Apr 1, 2016 Jun 30, 2016
Q1 2016 -31.3 -663 -105% Jan 1, 2016 Mar 31, 2016
Q4 2015 2.01K -757 -27.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 402 +5.25K Jul 1, 2015 Sep 30, 2015
Q2 2015 436 +4.68K Apr 1, 2015 Jun 30, 2015
Q1 2015 631 +3.84K Jan 1, 2015 Mar 31, 2015
Q4 2014 2.77K +5.7K Oct 1, 2014 Dec 31, 2014
Q3 2014 -4.85K -3.69K -319% Jul 1, 2014 Sep 30, 2014
Q2 2014 -4.24K +25.1K +85.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -3.2K -37.1K -109% Jan 1, 2014 Mar 31, 2014
Q4 2013 -2.93K +204 +6.52% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.16K +701 +37.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -29.3K -28.9K -6512% Apr 1, 2013 Jun 30, 2013
Q1 2013 33.9K +34.2K Jan 1, 2013 Mar 31, 2013
Q4 2012 -3.13K Oct 1, 2012 Dec 31, 2012
Q3 2012 -1.86K Jul 1, 2012 Sep 30, 2012
Q2 2012 -443 Apr 1, 2012 Jun 30, 2012
Q1 2012 -306 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.